Papas T S, Schafer M P
Ann N Y Acad Sci. 1977 Mar 4;284:566-75. doi: 10.1111/j.1749-6632.1977.tb21988.x.
Studies by other investigators have shown that adriamycin and daunorubicin exhibit antitumor and antiviral activity. A possible antiviral mechanism for the anthracycline compounds is the potent inhibition of viral DNA polymerases. Five anthracycline compounds were tested against purified Rauscher leukemia virus and avian myeloblastosis virus DNA polymerases. All compounds were found to be potent inhibitors of viral DNA polymerase activity. Inhibition was found to be primarily due to the planar ring structure (daunomycinone) common to all of these compounds. The degree of inhibition was dependent on the templates used: activated DNA, synthetic hybrids, poly(rA).dT12-18 and poly(rC).dG12-18, and the synthetic copolymer, poly(DA-dT). Alteration of the group substituent on the planar ring affected the degree of viral DNA polymerase inhibition. The inhibitory effects by anthracycline compounds appear to be relatively specific for viral polymerases.
其他研究人员的研究表明,阿霉素和柔红霉素具有抗肿瘤和抗病毒活性。蒽环类化合物可能的抗病毒机制是对病毒DNA聚合酶的有效抑制。对五种蒽环类化合物针对纯化的劳氏肉瘤病毒和禽成髓细胞瘤病毒DNA聚合酶进行了测试。发现所有化合物都是病毒DNA聚合酶活性的有效抑制剂。发现抑制主要归因于所有这些化合物共有的平面环结构(柔红霉酮)。抑制程度取决于所使用的模板:活化DNA、合成杂交体、聚(rA)·dT12-18和聚(rC)·dG12-18,以及合成共聚物聚(DA-dT)。平面环上基团取代基的改变影响病毒DNA聚合酶的抑制程度。蒽环类化合物的抑制作用似乎对病毒聚合酶具有相对特异性。